Glendon French

Glendon E.
French was the founder of Broncus Technologies, Inc., founded in 1997, where the title held was Director from 1997 to 2011.
Mr. French is also the founder of NDO Surgical, Inc...
Mr. French is President, Chief Executive Officer & Director at Pulmonx Corp.
since 2014.
Mr. French is Director at RadioTherapeutics Corp.
Mr. French is Director at CoLabs, Inc. since 2025.
Mr. French is Director at Myka Labs, Inc. since 2024.
Former positions include Chairman, Chief Executive Officer & Director at Applied Immune Sciences, Inc. from 1989 to 1992; President, Chief Executive Officer & Director at Asthmatx, Inc. from 2003 to 2010; Chairman & Chief Executive Officer at Imagyn Medical, Inc. from 1992 to 1994; Chief Executive Officer & Director at ApniCure, Inc. in 2014; Executive Chairman at Levita Magnetics International Corp.
from 2013 to 2022; Director at Pacific Physician Services, Inc.; Director at AMO Manufacturing USA LLC; Director at Percutaneous Systems, Inc.; Director at Webster Laboratories, Inc.; Director at LPL Technologies, Inc.; Independent Director at EDAP TMS SA from 2025 to 2026; Director at Michigan Bank, FSB (Troy, Michigan); Vice President-Marketing at C.
R.
Bard, Inc. (New Jersey) from 1993 to 1997; President-Pulmonary Endoscopy at Boston Scientific Corp.
from 2010 to 2012; President-Health & Education Sector at Aramark Services, Inc. in 1988; President at Dupont Critical Care, Inc. Education includes undergraduate degree from Dartmouth College and MBAistration from The Wharton School of the University of Pennsylvania.